O. Fitzgerald and B. Bresnihan, Synovial membrane cellularity and vascularity., Annals of the Rheumatic Diseases, vol.54, issue.6, pp.511-515, 1995.
DOI : 10.1136/ard.54.6.511

K. Dominic, F. Ahern, C. Gold, and D. Heller, Health related quality of life among adults with arthritis. Health and Quality of Life Outcomes, 2004.

M. Akil and R. Amos, ABC of Rheumatology: RHEUMATOID ARTHRITIS--I: CLINICAL FEATURES AND DIAGNOSIS, BMJ, vol.310, issue.6979, pp.587-590, 1995.
DOI : 10.1136/bmj.310.6979.587

F. Wolfe, The natural history of rheumatoid arthritis, J Rheumatol, vol.44, pp.13-22, 1996.

N. Sattar, D. Mccarey, H. Capell, and I. Mcinnes, Explaining How "High-Grade" Systemic Inflammation Accelerates Vascular Risk in Rheumatoid Arthritis, Circulation, vol.108, issue.24, pp.2957-2963, 200316.
DOI : 10.1161/01.CIR.0000099844.31524.05

J. Mitchell, R. Burkhauser, and P. T. , The importance of age, education, and comorbidity in the substantial earnings losses of individuals with symmetric polyarthritis, Arthritis & Rheumatism, vol.13, issue.3, pp.348-357, 1988.
DOI : 10.7326/0003-4819-76-4-573

H. Fuchs, J. Kaye, L. Callahan, E. Nance, and P. T. , Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease, J Rheumatol, vol.16, issue.5, pp.585-591, 1989.

D. Van-der-heijde, M. Van-leeuwen, V. Riel, P. Van-de-putte, and L. , Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method, J Rheumatol, 1995.

S. Van-doornum, G. Mccoll, and I. Wicks, Accelerated atherosclerosis : an extraarticular feature of rheumatoid arthritis ? Atrhitis Rheum, 2002.

F. Arnett, E. Sm, and D. Bloch, The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis & Rheumatism, vol.143, issue.3, 1988.
DOI : 10.1002/art.1780310302

T. Sokka and P. T. , quantitative joint assessment in rheumatoid arthritis, Clin Exp Rheumatol, 2005.

C. Sesin and C. Bingham, Remission in rheumatoid arthritis: wishful thinking or clinical reality? Semin Arthritis Rheum, pp.185-196, 2005.

O. Akgul and S. Ozgocmen, Classification criteria for spondyloarthropathies, World Journal of Orthopedics, vol.2, issue.12, pp.107-115, 2011.
DOI : 10.5312/wjo.v2.i12.07

M. Shamji, M. Bafaquh, and E. Tsai, The pathogenesis of ankylosing spondylitis, Neurosurgical Focus, vol.24, issue.1, p.3, 2008.
DOI : 10.3171/FOC/2008/24/1/E3

J. Braun and J. Sieper, Ankylosing spondylitis, The Lancet, vol.369, issue.9570, pp.1379-1390, 2007.
DOI : 10.1016/S0140-6736(07)60635-7

URL : https://hal.archives-ouvertes.fr/hal-00503871

M. Rudwaleit, D. Van-der-heijde, M. Khan, J. Braun, and J. Sieper, How to diagnose axial spondyloarthritis early, Annals of the Rheumatic Diseases, vol.63, issue.5, pp.535-543, 2004.
DOI : 10.1136/ard.2003.011247

S. Ozgocmen and M. Khan, Current Concept of Spondyloarthritis: Special Emphasis on Early Referral and Diagnosis, Current Rheumatology Reports, vol.10, issue.3, pp.409-414, 2012.
DOI : 10.1186/1546-0096-10-14

D. Poddubnyy, Improving diagnosis of ankylosing spondylitis and spondyloarthritis in general, International Journal of Clinical Rheumatology, vol.6, issue.6, pp.655-668, 2011.
DOI : 10.2217/ijr.11.54

M. Rudwaleit, A. Jurik, and K. Hermann, Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group, Annals of the Rheumatic Diseases, vol.68, issue.10, pp.1520-1527, 2009.
DOI : 10.1136/ard.2009.110767

M. Mansour, G. Cheema, and S. Naguwa, Ankylosing Spondylitis: A Contemporary Perspective on Diagnosis and Treatment, Seminars in Arthritis and Rheumatism, vol.36, issue.4, pp.210-223, 2007.
DOI : 10.1016/j.semarthrit.2006.08.003

E. Dakwar, J. Reddy, F. Vale, and J. Uribe, A review of the pathogenesis of ankylosing spondylitis, Neurosurgical Focus, vol.24, issue.1, p.2, 2008.
DOI : 10.3171/FOC/2008/24/1/E2

A. Boonen, Socioeconomic consequences of ankylosing spondylitis, Clin Exp Rheumatol, vol.20, issue.6, pp.23-26, 2002.

J. Gran and J. Skomsvoll, The outcome of ankylosing spondylitis: a study of 100 patients., Rheumatology, vol.36, issue.7, pp.766-771, 1997.
DOI : 10.1093/rheumatology/36.7.766

S. Van-der-linden, D. Van-der-hiejde, and J. Braun, Diagnosing ankylosing spondylitis. In: Kelley's Textbook of Rheumatology, pp.1124-1141

M. Rudwaleit and D. Baeten, Ankylosing spondylitis and bowel disease, Best Practice & Research Clinical Rheumatology, vol.20, issue.3, 2006.
DOI : 10.1016/j.berh.2006.03.010

L. Edmunds, J. Elswood, L. Kennedy, and A. Calin, Primary ankylosing spondylitis, psoriatic and enteropathic spondyloarthropathy: a controlled analysis, J Rheumatol, vol.18, issue.5, pp.696-698, 1991.

S. Sukenik, A. Pras, D. Buskila, A. Katz, Y. Snir et al., Cardiovascular manifestations of ankylosing spondylitis, Clinical Rheumatology, vol.45, issue.4, pp.588-592, 1987.
DOI : 10.1016/S0025-7125(16)31337-2

R. Bessant and A. Keat, How should clinicians manage osteoporosis in ankylosing spondylitis?, J Rheumatol, vol.29, issue.7, pp.1511-1519, 2002.

A. Khalessi, B. Oh, and M. Wang, Medical management of ankylosing spondylitis, Neurosurgical Focus, vol.24, issue.1, p.4, 2008.
DOI : 10.3171/FOC/2008/24/1/E4

J. Braun, M. Khan, and J. Sieper, Enthesitis and ankylosis in spondyloarthropathy: What is the target of the immune response?, Annals of the Rheumatic Diseases, vol.59, issue.12, pp.985-994, 2000.
DOI : 10.1136/ard.59.12.985

J. Zochling, Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Sp, Arthritis Care & Research, vol.49, issue.Suppl, pp.47-58, 2011.
DOI : 10.1002/art.11412

T. Osborn and W. Wilke, Psoriatic Arthritis, pp.310-327
DOI : 10.1002/9780470750704.ch21

P. Mease, Measures of psoriatic arthritis. Arthritis Care Research, 2011.

D. Gladman, Psoriatic arthritis In: Kelley's Textbook of Rheumatology, pp.1155-1164

D. Gladman, C. Antoni, P. Mease, D. Clegg, and P. Nash, Psoriatic arthritis: epidemiology, clinical features, course, and outcome, Annals of the Rheumatic Diseases, vol.64, issue.suppl_2, pp.14-17, 2005.
DOI : 10.1136/ard.2004.032482

U. Mrowietz, J. Elder, and J. Barker, The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients, Archives of Dermatological Research, vol.12, issue.3 Pt 1, pp.309-319, 2006.
DOI : 10.5551/jat.12.295

C. Ackermann and A. Kavanaugh, Economic Burden of Psoriatic Arthritis, PharmacoEconomics, vol.33, issue.11, pp.121-129, 2008.
DOI : 10.2165/00019053-200826020-00003

D. Mccarey and I. Mcinnes, Psoriatic arthritis: Current topics, Current Rheumatology Reports, vol.8, issue.6, pp.442-448, 2007.
DOI : 10.4049/jimmunol.172.3.1935

W. Taylor, D. Gladman, P. Helliwell, A. Marchesoni, P. Mease et al., Classification criteria for psoriatic arthritis: Development of new criteria from a large international study, Arthritis & Rheumatism, vol.59, issue.8, pp.2665-2673, 2006.
DOI : 10.1176/ajp.151.5.650

V. Chandran, C. Schentag, and D. Gladman, Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis, Arthritis & Rheumatism, vol.56, issue.8, pp.1560-1563, 2007.
DOI : 10.1002/art.23104

I. Olivieri, D. Angelo, S. Padula, A. Palazzi, and C. , The challenge of early diagnosis of psoriatic arthritis, J Rheumatol, vol.35, issue.1, pp.3-5, 2008.

R. Langley and C. Ellis, Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment, Journal of the American Academy of Dermatology, vol.51, issue.4, pp.563-569, 2004.
DOI : 10.1016/j.jaad.2004.04.012

N. Scheinfeld, Infliximab: A review focusing on psoriatic arthritis, US Dermatology Review, pp.40-45, 2006.

S. Feldman and G. Krueger, Psoriasis assessment tools in clinical trials, Annals of the Rheumatic Diseases, vol.64, issue.suppl_2, pp.65-68, 2005.
DOI : 10.1136/ard.2004.031237

A. Zink, J. Braun, J. Listing, and J. Wollenhaupt, Disability and handicap in rheumatoid arthritis and ankylosing spondylitis-results from the German rheumatological database. German Collaborative Arthritis Centers, J Rheumatol, vol.27, issue.3, pp.613-622, 2000.

H. Zachariae, Prevalence of Joint Disease in Patients with Psoriasis, American Journal of Clinical Dermatology, vol.132, issue.4, pp.441-448, 2003.
DOI : 10.2165/00128071-200304070-00001

P. Emery, Treatment of rheumatoid arthritis, BMJ, vol.332, issue.7534, pp.152-157, 2006.
DOI : 10.1136/bmj.332.7534.152

T. Kennedy, C. Mccabe, and G. Struthers, BSR guidelines on standards of care for persons with rheumatoid arthritis, Rheumatology, vol.44, issue.4, pp.553-559, 2005.
DOI : 10.1093/rheumatology/keh554

S. Kyle, D. Chandler, and C. Griffiths, Guideline for anti-TNF-?? therapy in psoriatic arthritis, Rheumatology, vol.44, issue.3, pp.390-397, 2005.
DOI : 10.1093/rheumatology/keh514

M. Mansour, G. Cheema, and S. Naguwa, Ankylosing Spondylitis: A Contemporary Perspective on Diagnosis and Treatment, Seminars in Arthritis and Rheumatism, vol.36, issue.4, pp.210-233, 2007.
DOI : 10.1016/j.semarthrit.2006.08.003

J. Braun and J. Sieper, Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti- TNF-alpha therapy and other novel approaches, Arthritis Research, vol.4, issue.5, pp.307-328, 2002.
DOI : 10.1186/ar592

M. Genovese and E. Harris, Chapter 67: Treatment of rheumatoid arthritis. Kelley's textbook of rheumatology, pp.1079-1100, 2005.

T. Osborn and W. Wilke, Chapter 21: Psoriatic arthritis. Handbook of Psoriasis, pp.310-327, 2004.

V. Chandran, C. Schentag, and D. Gladman, Reappraisal of the effectiveness of methotrexate in psoriatic arthritis: results from a longitudinal observational cohort, J Rheumatol, vol.35, issue.3, pp.469-71, 2008.

D. Tracey, L. Klareskog, E. Sasso, J. Salfeld, and P. Tak, Tumor necrosis factor antagonist mechanisms of action: A comprehensive review, Pharmacology & Therapeutics, vol.117, issue.2, pp.244-79, 2008.
DOI : 10.1016/j.pharmthera.2007.10.001

T. Kohno, L. Tam, S. Stevens, and J. Louie, Binding Characteristics of Tumor Necrosis Factor Receptor-Fc Fusion Proteins vs Anti-Tumor Necrosis Factor mAbs, Journal of Investigative Dermatology Symposium Proceedings, vol.12, issue.1, pp.5-8, 2007.
DOI : 10.1038/sj.jidsymp.5650034

J. Davis, J. Van-der-heijde, D. Braun, and J. , Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial, Arthritis & Rheumatism, vol.44, issue.11, pp.3230-3236, 2003.
DOI : 10.1002/art.11325

C. Sledge and . Chapter, Introduction to surgical management of patients with arthritis. Kelley's textbook of rheumatology, pp.1829-1835, 2005.

A. College and . Rheumatology, ACR) Guidelines for the management of rheumatoid arthritis, Update. Arthritis Rheum, vol.46, issue.2, pp.328-346, 2002.

B. Combe, R. Landewe, and C. Lukas, EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT), Annals of the Rheumatic Diseases, vol.66, issue.1
DOI : 10.1136/ard.2005.044354

J. Fransen, The Disease Activity Score and the EULAR Response Criteria, Rheumatic Disease Clinics of North America, vol.35, issue.4, 2005.
DOI : 10.1016/j.rdc.2009.10.001

J. Zochling, D. Van-der-heijde, and R. Burgos-vargas, ASAS/EULAR recommendations for the management of ankylosing spondylitis, Annals of the Rheumatic Diseases, vol.65, issue.4, pp.442-52, 2006.
DOI : 10.1136/ard.2005.041137

URL : https://hal.archives-ouvertes.fr/hal-00503871

J. Braun, R. Van-den-berg, X. Baraliakos, and H. Boehm, 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis, Annals of the Rheumatic Diseases, vol.70, issue.6, pp.896-904, 2011.
DOI : 10.1136/ard.2011.151027

S. Aydin, W. Maksymowych, and A. Bennett, Validation of the ASAS criteria and definition of a positive MRI of the sacroiliac joint in an inception cohort of axial spondyloarthritis followed up for 8 years, Annals of the Rheumatic Diseases, vol.71, issue.1, pp.56-60, 2012.
DOI : 10.1136/ard.2011.153064

D. Van-der-heijde, J. Sieper, and W. Maksymowych, 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis, Annals of the Rheumatic Diseases, vol.70, issue.6, pp.905-908, 2011.
DOI : 10.1136/ard.2011.151563

J. Sieper, M. Rudwaleit, and X. Baraliakos, The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis, Annals of the Rheumatic Diseases, vol.68, issue.Suppl 2, pp.1-44, 2009.
DOI : 10.1136/ard.2008.104018

C. Salvarani, I. Olivieri, and N. Pipitone, Recommendations of the Italian Society for Rheumatology for the use of biologic (TNF-alpha blocking) agents in the treatment of psoriatic arthritis, Clin Exp Rheumatol, vol.24, issue.1, pp.70-78, 2006.

E. Bénépali, Les biosimilaires en 15 questions de Claude Le Pen